Aaron Schuchart is Chief Business Officer of LUMOS PHARMA, INC.. Currently has a direct ownership of 0 shares of LUMO, which is worth approximately $0. The most recent transaction as insider was on Dec 12, 2024, when has been sold 8,179 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Aaron Schuchart Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 12 2024
SELL
Sale (or disposition) back to the issuer
-
8,179 Reduced 100.0%
0 Common Stock
Apr 01 2024
BUY
Grant, award, or other acquisition
$2,840 $2.84 p/Share
1,000 Added 13.02%
6,679 Common Stock
Feb 01 2024
SELL
Payment of exercise price or tax liability
$608 $3.01 p/Share
202 Reduced 3.43%
5,679 Common Stock
Feb 01 2023
SELL
Payment of exercise price or tax liability
$366 $3.52 p/Share
104 Reduced 1.9%
5,381 Common Stock
Feb 01 2023
BUY
Grant, award, or other acquisition
$3,520 $3.52 p/Share
1,000 Added 15.42%
5,485 Common Stock
Feb 01 2022
SELL
Payment of exercise price or tax liability
$521 $10.02 p/Share
52 Reduced 1.29%
3,985 Common Stock
Feb 01 2022
BUY
Grant, award, or other acquisition
$10,020 $10.02 p/Share
1,000 Added 19.85%
4,037 Common Stock
Aug 12 2021
BUY
Open market or private purchase
$12,614 $7.42 p/Share
1,700 Added 35.89%
3,037 Common Stock
Aug 11 2021
BUY
Open market or private purchase
$2,205 $7.35 p/Share
300 Added 18.33%
1,337 Common Stock
AS

Aaron Schuchart

Chief Business Officer
Austin, TX

Track Institutional and Insider Activities on LUMO

Follow LUMOS PHARMA, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LUMO shares.

Notify only if

Insider Trading

Get notified when an Lumos Pharma, Inc. insider buys or sells LUMO shares.

Notify only if

News

Receive news related to LUMOS PHARMA, INC.

Track Activities on LUMO